30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold;
or
on earlier notification by FDA that the clinical investigations in the IND may begin.
When the 30 days are up (01-Oct) either Kenny tells SHs there's no Hold, or in Kenny's case, he gives silence, equating to a Hold.